Genus plc (LON:GNS) has been given a consensus rating of “Buy” by the seven research firms that are currently covering the company, reports. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is GBX 3,082.83 ($40.28).

Several brokerages recently issued reports on GNS. Peel Hunt reissued a “buy” rating on shares of Genus in a research note on Wednesday, November 20th. HSBC raised their price objective on Genus from GBX 3,000 ($39.20) to GBX 3,260 ($42.60) and gave the stock a “buy” rating in a report on Wednesday, November 13th. Peel Hunt reaffirmed a “buy” rating and set a GBX 3,200 ($41.81) target price on shares of Genus in a research report on Thursday, November 14th. Jefferies Financial Group initiated coverage on Genus in a report on Friday, November 15th. They issued a “hold” rating and a GBX 3,272 ($42.75) target price for the company. Finally, Liberum Capital increased their price target on Genus from GBX 2,800 ($36.59) to GBX 3,450 ($45.08) and gave the stock a “buy” rating in a research report on Thursday, November 28th.

In other Genus news, insider Lysanne Gray sold 1,298 shares of Genus stock in a transaction dated Monday, September 16th. The stock was sold at an average price of GBX 2,858 ($37.34), for a total value of £37,096.84 ($48,473.59). Also, insider Dan Hartley sold 7,267 shares of the business’s stock in a transaction dated Wednesday, September 18th. The stock was sold at an average price of GBX 2,894 ($37.82), for a total transaction of £210,306.98 ($274,803.32). Insiders sold a total of 22,851 shares of company stock valued at $67,205,592 in the last ninety days.

Genus stock opened at GBX 3,166 ($41.37) on Friday. The company has a 50 day moving average price of GBX 3,015.56 and a 200-day moving average price of GBX 2,765.22. The company has a debt-to-equity ratio of 21.92, a quick ratio of 1.19 and a current ratio of 2.01. Genus has a fifty-two week low of GBX 2,122 ($27.73) and a fifty-two week high of GBX 3,215.59 ($42.02). The company has a market capitalization of $2.07 billion and a PE ratio of 266.05.

The firm also recently declared a dividend, which was paid on Friday, November 29th. Stockholders of record on Thursday, November 7th were issued a GBX 18.80 ($0.25) dividend. The ex-dividend date was Thursday, November 7th. This represents a dividend yield of 0.68%. This is a positive change from Genus’s previous dividend of $8.90. Genus’s payout ratio is currently 2.35%.

About Genus

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Recommended Story: What is Depreciation?

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with's FREE daily email newsletter.